Back

Clinical features and long-term outcomes of venous thromboembolism in the warfarin era versus in the direct oral anticoagulant era

28 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Current anticoagulation of acute pulmonary embolism: how does it impact outcomes? Venous Thromboembolism ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kazuhisa Kaneda

Kyoto University Graduate School of Medicine, Kyoto (Japan)

6 More presentations in this session

Presentation thumbnail
Clinical long-term outcomes in fragile patients with venous thromboembolism receiving direct oral anticoagulant: From the COMMAND VTE Registry-2
Assistant Professor Y. Ogihara (Tsu, JP)
Abstract Slides Video
Presentation thumbnail
Three-year quality of life and the effect on functional limitation and anticoagulation adherence in patients with acute pulmonary emboli
Ms M. Mohammadi (Tehran, IR) Professor P. Sadeghipour (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Different impact of each score component in the simplified PESI score on acute mortality of patients with pulmonary embolism in the era of direct oral anticoagulant
Doctor N. Ryusuke (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Development and validation of a clinical prediction model for the diagnostic management of acute pulmonary embolism: an individual participant data meta-analysis.
Doctor G. Geersing (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Sex differences in outcomes among patients hospitalized with pulmonary embolism: insights from National Inpatient Sample 2002-2020.
Doctor I. Shatla (Kansas City, US)
Abstract Slides Video

Access the full session

Session thumbnail
Current anticoagulation of acute pulmonary embolism: how does it impact outcomes?

The Event

Event poster

ESC Congress 2023

28 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era
thumbnail
Congress Presentation
The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2
thumbnail
Congress Presentation
Clinical characteristics and outcomes of super-low-dose edoxaban of 15 mg in patients with acute venous thromboembolism: insight from the COMMAND VTE Registry-2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources